2-(3-Cyanobenzoyl)-5-(1,3-dioxolan-2-yl)thiophene, 97.0%, 1g

3-(bromomethyl)-5-(trifluoromethyl)-1,2,4-oxadiazole, 95.0%, 250mg

5H-pyrrolo[3,2-d]pyrimidine, 95.0%, 5g

(4-Methylmorpholin-2-yl)methanamine, 95.0%, 250mg

1-((2R,5S)-5-(Hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione, 95.0%, 5g

N,N-diméthylformamide, PEPTIPURE®, min 99,8 %, pour la synthèse peptidique, 10 l

Methyl D-3-Phenyllactate>98.0%(GC)5g

(7-Bromo-2-chloroquinolin-3-yl)methanol, 98%, 100mg

4-Butoxyphthalonitrile, 97%, 5g

tert-Butyl (4-bromo-3-cyano-7-fluorobenzo[b]thiophen-2-yl)carbamate, 98%, 10g

[(3-chloro-4-methoxyphenyl)methyl](methyl)amine, 97%, 5g

(E)-3-(2-Nitrovinyl)pyridine, 95.0%, 250mg

Diethyl butylphosphonate, 95+%, 1g